[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology, metabolic dysfunction-associated steatohepatitis (MASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of MASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 66, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mark Joseph Vignola Ph.D.", "age": 45, "title": "CFO & Treasurer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 974160, "exercisedValue": 0, "unexercisedValue": 35194}, {"maxAge": 1, "name": "Ms. Amy L. Burroughs M.B.A.", "age": 53, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elona  Kogan Esq., J.D.", "age": 54, "title": "Chief Legal Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey R. Jasper Ph.D.", "title": "Senior Vice President of Research", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil T. Kuriakose M.D.", "age": 43, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melita Sun Jung", "age": 46, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Harris", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Sieminski", "title": "Senior Vice President of Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pamela  Danagher", "title": "Senior Vice President of Regulatory Affairs & Quality Assurance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Eric Strauss", "age": 37, "title": "VP of Finance & Controller", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1727740800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.1, "open": 7.97, "dayLow": 7.82, "dayHigh": 8.37, "regularMarketPreviousClose": 8.1, "regularMarketOpen": 7.97, "regularMarketDayLow": 7.82, "regularMarketDayHigh": 8.37, "beta": -0.384, "forwardPE": -5.942029, "volume": 1428278, "regularMarketVolume": 1428278, "averageVolume": 1930847, "averageVolume10days": 1586270, "averageDailyVolume10Day": 1586270, "bid": 8.18, "ask": 8.24, "bidSize": 100, "askSize": 300, "marketCap": 692375168, "fiftyTwoWeekLow": 3.26, "fiftyTwoWeekHigh": 11.4, "fiftyDayAverage": 8.2333, "twoHundredDayAverage": 6.939575, "currency": "USD", "enterpriseValue": 352001664, "floatShares": 49251893, "sharesOutstanding": 84436000, "sharesShort": 3763437, "sharesShortPriorMonth": 1804399, "sharesShortPreviousMonthDate": 1723680000, "dateShortInterest": 1726185600, "sharesPercentSharesOut": 0.0446, "heldPercentInsiders": 0.0013600001, "heldPercentInstitutions": 0.84325, "shortRatio": 1.29, "shortPercentOfFloat": 0.049000002, "bookValue": 3.109, "priceToBook": 2.637504, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -95895000, "trailingEps": -1.32, "forwardEps": -1.38, "lastSplitFactor": "1000:50", "lastSplitDate": 1383523200, "enterpriseToEbitda": -3.262, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "TERN", "underlyingSymbol": "TERN", "shortName": "Terns Pharmaceuticals, Inc.", "longName": "Terns Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1612535400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "7e7e889b-1f93-38a3-8cbf-64bb942bfd16", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.2, "targetHighPrice": 30.0, "targetLowPrice": 5.5, "targetMeanPrice": 18.92, "targetMedianPrice": 19.0, "recommendationMean": 2.1, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 225296992, "totalCashPerShare": 3.202, "ebitda": -107911000, "totalDebt": 249000, "quickRatio": 20.566, "currentRatio": 21.017, "debtToEquity": 0.114, "returnOnAssets": -0.25987, "returnOnEquity": -0.38916, "freeCashflow": -46111624, "operatingCashflow": -78992000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-03"}]